United States National Health Interview Survey 2008
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
HPV vaccines
Dataset Records for HPV vaccines
Displaying 251 - 300 of 390
HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data
GHDx Entry last modified on: Mar 14, 2022
United States - Alaska Supplemental Behavioral Risk Factor Surveillance System 2008
Survey:
Cross-sectional - Household - Individual - Interview
HPV Vaccinations in Lublin Region, Poland
GHDx Entry last modified on: Apr 14, 2022
Association between mothers screening uptake and daughters HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign
GHDx Entry last modified on: Jan 31, 2024
Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine Among U.S. Women and Girls: A National Survey
GHDx Entry last modified on: Mar 14, 2022
ACA Provisions Associated With Increase In Percentage Of Young Adult Women Initiating And Completing The HPV Vaccine
GHDx Entry last modified on: Apr 14, 2022
Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses
GHDx Entry last modified on: Jan 31, 2023
Trends in HPV Vaccine Initiation and Completion among Girls in Texas: Behavioral Risk Factor Surveillance System Data, 2008-2010
GHDx Entry last modified on: Jan 31, 2024
Cost-effectiveness of different human papillomavirus vaccines in Singapore
GHDx Entry last modified on: Jan 31, 2023
A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females
GHDx Entry last modified on: Jan 31, 2023
Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada
GHDx Entry last modified on: Jan 31, 2024
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
GHDx Entry last modified on: Jan 31, 2023
Coverage from Ontario, Canadas school-based HPV vaccine program: the first three years
GHDx Entry last modified on: Jan 31, 2024
Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups
GHDx Entry last modified on: Mar 14, 2022
HPV Vaccine utilization, Alberta 2008/09-2013/14 School year
GHDx Entry last modified on: Jan 31, 2024
Mothers and their daughters use of preventive measures against cervical cancer
GHDx Entry last modified on: Mar 14, 2022
Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey
GHDx Entry last modified on: Mar 14, 2022
Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study
GHDx Entry last modified on: Apr 14, 2022
Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008-2012 National Health Interview Survey
GHDx Entry last modified on: Apr 14, 2022
United States National Survey of Children's Health 2007-2008
Survey:
Cross-sectional - Household - Interview
The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy
GHDx Entry last modified on: May 30, 2020
United States National Health and Nutrition Examination Survey 2007-2008
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012
GHDx Entry last modified on: Mar 14, 2022
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States
GHDx Entry last modified on: Apr 14, 2022
Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis
GHDx Entry last modified on: May 30, 2020
Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer
GHDx Entry last modified on: May 30, 2020
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008
GHDx Entry last modified on: Mar 14, 2022
Use of health care reimbursement data to estimate vaccination coverage in France: Example of hepatitis B, meningitis C, and human papillomavirus vaccination
GHDx Entry last modified on: Mar 14, 2022
Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States
GHDx Entry last modified on: Jan 31, 2023
Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
GHDx Entry last modified on: Mar 14, 2022
Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
GHDx Entry last modified on: Jan 31, 2023
Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators
GHDx Entry last modified on: Mar 14, 2022
Marshall Islands Ministry of Health Annual Report 2009
Report:
Financial - Inpatient - Operational - Outpatient
Estimating human papillomavirus vaccination coverage among young women in Victoria and reasons for non-vaccination
GHDx Entry last modified on: Jan 31, 2024
Papillomavirus and cancers: should we extend vaccination to boys in France?
GHDx Entry last modified on: Mar 14, 2022
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand
GHDx Entry last modified on: Jan 31, 2023
Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region
GHDx Entry last modified on: Jan 31, 2024
Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide
GHDx Entry last modified on: Mar 14, 2022
Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010
GHDx Entry last modified on: Mar 14, 2022
Malaysia Health Indicators 2013
Report:
Discharge - Inpatient - Outpatient - Subnationally representative
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
GHDx Entry last modified on: May 30, 2020
Factors influencing uptake of HPV vaccination among girls in Germany
GHDx Entry last modified on: Mar 14, 2022
Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: Results from the Childhood National Immunization Coverage Survey, 2013
GHDx Entry last modified on: Mar 14, 2022
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014
GHDx Entry last modified on: Mar 14, 2022
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
GHDx Entry last modified on: Jan 31, 2023
Present status of human papillomavirus vaccine development and implementation
GHDx Entry last modified on: Mar 14, 2022
Subscribe